Company intelligence / Profile preview

EndoBiologics

Shelbyville, Kentucky, United States

Ownership: Private
Development stage: Other

Overview

Endo-Biologics is a specialized contract laboratory providing critical quality control services to the pharmaceutical, biotechnology, and medical device industries. The company focuses on bacterial endotoxin testing (BET) using the Limulus Amebocyte Lysate (LAL) methodology, as well as (1→3)-β-D-glucan testing. Their services are essential for ensuring the safety and sterility of injectable drugs and implantable devices by detecting pyrogenic contaminants. Based in Kentucky, the company operates as an independent testing facility supporting regulatory compliance for life science manufacturers.

Industry: Contract Research Organization

Beyond the preview

Go deeper on EndoBiologics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EndoBiologics.

Explore the full profile